Some distinctions between flavin-containing and cytochrome P450 monooxygenases

This publication has 36 references indexed in Scilit:

• Discovery of Novel Flavin-Containing Monooxygenase 3 (FMO3) Single Nucleotide Polymorphisms and Functional Analysis of Upstream Haplotype Variants
  Molecular Pharmacology, 2005
• Effect of pregnancy on a measure of FMO3 activity
  British Journal of Clinical Pharmacology, 2005
• Vacuolar Degradation of Rat Liver CYP2B1 in Saccharomyces cerevisiae: Further Validation of the Yeast Model and Structural Implications for the Degradation of Mammalian Endoplasmic Reticulum P450 Proteins
  Molecular Pharmacology, 2005
• GENETIC POLYMORPHISMS OF FLAVIN-CONTAINING MONOOXYGENASE (FMO)
  Drug Metabolism Reviews, 2002
• In vitro evaluation of potential in vivo probes for human flavin‐containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms
  British Journal of Clinical Pharmacology, 2000
• N-Glycosylation of Pig Flavin-Containing Monooxygenase Form 1: Determination of the Site of Protein Modification by Mass Spectrometry
  Chemical Research in Toxicology, 1998
• Prochiral sulfides as in vitro probes for multiple forms of the flavin-containing monooxygenase
  Chemico-Biological Interactions, 1995
• The Mammalian Flavin-Containing Monooxygenases: Molecular Characterization and Regulation of Expression
  Toxicology and Applied Pharmacology, 1994
• Evolution of the P450 gene superfamily:
  Trends in Genetics, 1990
• POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE
  The Lancet, 1977